Breaking News

Morphotek Selects Cryoport to Manage Cold Chain Logistics

To provide cold chain logistics support for shipments of Morphotek’s R&D materials

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cryoport, Inc. has been selected by Morphotek to provide cold chain logistics support for shipments of Morphotek’s R&D materials.   Morphotek, a subsidiary of Eisai Inc., develops novel classes of biologic-based products to treat cancer, inflammation and infectious diseases. Morphotek’ Human MORPHODOMA technology employs an ex vivo immunization process in combination with morphogenics to generate fully human antibodies targeted against disease-associated antigens.     Its Libradoma techn...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters